314 related articles for article (PubMed ID: 32767244)
1. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
2. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
3. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
4. Update on the biology and management of canine osteosarcoma.
Chun R; de Lorimier LP
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):491-516, vi. PubMed ID: 12852233
[TBL] [Abstract][Full Text] [Related]
5. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Morello E; Martano M; Buracco P
Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of osteosarcoma in four dogs.
Mehl ML; Withrow SJ; Seguin B; Powers BE; Dernell WS; Pardo AD; Rosenthal RC; Dolginow SZ; Park RD
J Am Vet Med Assoc; 2001 Sep; 219(5):614-7. PubMed ID: 11549088
[TBL] [Abstract][Full Text] [Related]
8. Recent and current clinical trials in canine appendicular osteosarcoma.
Poon AC; Matsuyama A; Mutsaers AJ
Can Vet J; 2020 Mar; 61(3):301-308. PubMed ID: 32165755
[TBL] [Abstract][Full Text] [Related]
9. Updates in Osteosarcoma.
Bryan JN
Vet Clin North Am Small Anim Pract; 2024 May; 54(3):523-539. PubMed ID: 38158305
[TBL] [Abstract][Full Text] [Related]
10. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.
Simpson S; Dunning MD; de Brot S; Grau-Roma L; Mongan NP; Rutland CS
Acta Vet Scand; 2017 Oct; 59(1):71. PubMed ID: 29065898
[TBL] [Abstract][Full Text] [Related]
11. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.
Mason NJ; Gnanandarajah JS; Engiles JB; Gray F; Laughlin D; Gaurnier-Hausser A; Wallecha A; Huebner M; Paterson Y
Clin Cancer Res; 2016 Sep; 22(17):4380-90. PubMed ID: 26994144
[TBL] [Abstract][Full Text] [Related]
13. Studies on chemotherapy and immunotherapy in canine lymphosarcoma and osteosarcoma.
Owen LN; Bostock DE; Lavelle RB
Bibl Haematol; 1975 Oct; (43):522-3. PubMed ID: 786263
[No Abstract] [Full Text] [Related]
14. Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.
Cascio MJ; Whitley EM; Sahay B; Cortes-Hinojosa G; Chang LJ; Cowart J; Salute M; Sayour E; Dark M; Sandoval Z; Mitchell DA; Milner RJ
Vet Immunol Immunopathol; 2021 Feb; 232():110169. PubMed ID: 33387703
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma.
Rissetto KC; Rindt H; Selting KA; Villamil JA; Henry CJ; Reinero CR
Vet Immunol Immunopathol; 2010 May; 135(1-2):137-145. PubMed ID: 20197202
[TBL] [Abstract][Full Text] [Related]
16. Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function.
Tuohy JL; Lascelles BD; Griffith EH; Fogle JE
J Vet Intern Med; 2016 Jul; 30(4):1167-78. PubMed ID: 27338235
[TBL] [Abstract][Full Text] [Related]
17. Outcome and Metastatic Behavior of Canine Sinonasal Osteosarcoma (2005-2015).
Galloway A; Lana S; Thamm D; Boss K
J Am Anim Hosp Assoc; 2020; 56(2):98-105. PubMed ID: 31961217
[No Abstract] [Full Text] [Related]
18. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
19. What do we know about canine osteosarcoma treatment? Review.
Szewczyk M; Lechowski R; Zabielska K
Vet Res Commun; 2015 Mar; 39(1):61-7. PubMed ID: 25422073
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.
Rici REG; Will SEAL; Luna ACL; Melo LF; Santos AC; Rodrigues RF; Leandro RM; Maria DA
Vet Comp Oncol; 2018 Dec; 16(4):478-488. PubMed ID: 29781255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
